Home/Filings/4/0001225208-21-003232
4//SEC Filing

Johnson Aimee 4

Accession 0001225208-21-003232

CIK 0001617640other

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 7:12 PM ET

Size

20.2 KB

Accession

0001225208-21-003232

Insider Transaction Report

Form 4
Period: 2021-02-17
Johnson Aimee
Chief Marketing Officer
Transactions
  • Sale

    Class C Capital Stock

    2021-02-17$191.74/sh100$19,17455,216 total
  • Sale

    Class C Capital Stock

    2021-02-17$190.70/sh101$19,26155,115 total
  • Sale

    Class C Capital Stock

    2021-02-17$189.82/sh400$75,92954,715 total
  • Sale

    Class C Capital Stock

    2021-02-17$188.39/sh576$108,51054,139 total
  • Exercise/Conversion

    Class C Capital Stock

    2021-02-18$29.09/sh+5,688$165,46459,827 total
  • Exercise/Conversion

    Class C Capital Stock

    2021-02-18$40.36/sh+3,384$136,57863,211 total
  • Sale

    Class C Capital Stock

    2021-02-18$183.47/sh12,375$2,270,39350,836 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-02-183,38427,061 total
    Exercise: $40.36From: 2019-05-15Exp: 2029-03-01Class C Capital Stock (3,384 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-02-185,68845,506 total
    Exercise: $29.09From: 2019-11-26Exp: 2028-12-20Class C Capital Stock (5,688 underlying)
Footnotes (8)
  • [F1]Represents shares sold to cover tax withholding due upon vesting of restricted stock units.
  • [F2]The reported price is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $190.69 to $191.52. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F3]The reported price is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $189.41 to $190.20. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F4]The reported price is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $187.96 to $188.73. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F5]7,585 shares of the reported balance represents a grant of restricted stock units that vested as to 1/4th of the total amount of shares subject to the grant on November 26, 2019 and an additional 1/16th shall become vested on each issuer quarterly vesting date occurring thereafter until the restricted stock units are fully vested. 1,266 shares of the reported balance represents a grant of restricted stock units that vested as to 1/16th of the total amount of shares subject to the grant, respectively on each of May 15, 2019, August 14, 2019 and November 13, 2019 and an additional 1/16th shall become vested on each issuer quarterly vesting date occurring thereafter until the restricted stock units are fully vested.
  • [F6]The reported price is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $183.2737 to $183.86. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F7]Date at which first vesting occurs us indicated. 1/16th of the total number of shares subject to the option become exercisable at the first vesting date and an additional 1/16th become exercisable on each issuer quarterly vesting date occurring thereafter until the option is fully vested.
  • [F8]Date at which first vesting occurs is indicated. 1/4th of the total number of shares subject to the option become exercisable at the first vesting date and an additional 1/16th become exercisable on each issuer quarterly vesting date occurring thereafter until the option is fully vested.

Documents

1 file

Issuer

ZILLOW GROUP, INC.

CIK 0001617640

Entity typeother

Related Parties

1
  • filerCIK 0001797251

Filing Metadata

Form type
4
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 7:12 PM ET
Size
20.2 KB